C–X–C Ligand 10 and C–X–C Receptor 3 Status Can Predict Tamoxifen Treatment Response in Breast Cancer Patients

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-014-2933-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CXCR3 (Chemokine (C-X-C Motif) Receptor 3)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

High Circulating Chemokines (C-X-C Motif) Ligand 9, and (C-X-C Motif) Ligand 11, in Hepatitis C-Associated Cryoglobulinemia

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2013English

Epigenetic Up-Regulation of C-C Chemokine Receptor 7 and C-X-C Chemokine Receptor 4 Expression in Melanoma Cells

Cancer Research
Cancer ResearchOncology
2005English

Chemokine (C-X-C Motif) Ligand 1 (CXCL1) Is Associated With Tumor Progression and Poor Prognosis in Patients With Colorectal Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Immunosenescent CD8+ T Cells and C-X-C Chemokine Receptor Type 3 Chemokines Are Increased in Human Hypertension

Hypertension
Internal Medicine
2013English

C-Terminal–modified LY2510924: A Versatile Scaffold for Targeting C-X-C Chemokine Receptor Type 4

Scientific Reports
Multidisciplinary
2019English

Figure 3: X-Ray of C. Caretta.

English

Prostaglandin F2 -F-Prostanoid Receptor Signaling Promotes Neutrophil Chemotaxis via Chemokine (C-X-C Motif) Ligand 1 in Endometrial Adenocarcinoma

Cancer Research
Cancer ResearchOncology
2009English

Expression of C-X-C Chemokine Receptor Types 1/2 in Patients With Gastric Carcinoma: Clinicopathological Correlations and Significance

Oncology Letters
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy